- Home
- SILC vs OKYO Comparison
SILC vs OKYO Comparison
Compare SILC & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SILC | OKYO |
|---|---|---|
| Founded | 1987 | 2007 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.3M | 79.7M |
| IPO Year | 1994 | 2022 |
Fundamental Metrics
Financial Performance| Metric | SILC | OKYO |
|---|---|---|
| Price | $15.45 | $2.98 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 30.3K | ★ 133.3K |
| Earning Date | 01-29-2026 | 07-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $59,509,000.00 | N/A |
| Revenue This Year | $6.48 | N/A |
| Revenue Next Year | $14.36 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.44 | $0.90 |
| 52 Week High | $19.37 | $3.35 |
Technical Indicators
Market Signals| Indicator | SILC | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 60.55 | 72.25 |
| Support Level | $14.88 | $1.90 |
| Resistance Level | $16.43 | $2.48 |
| Average True Range (ATR) | 0.66 | 0.22 |
| MACD | 0.17 | 0.11 |
| Stochastic Oscillator | 69.51 | 95.87 |
Price Performance
Historical ComparisonAbout SILC Silicom Ltd
Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, FPGA-Based Cards, x86 Open Appliances, Bypass Switches, and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.